BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 23121543)

  • 1. Agraphia in patients with frontotemporal dementia and parkinsonism linked to chromosome 17 with P301L MAPT mutation: dysexecutive, aphasic, apraxic or spatial phenomenon?
    Sitek EJ; Narozanska E; Barczak A; Jasinska-Myga B; Harciarek M; Chodakowska-Zebrowska M; Kubiak M; Wieczorek D; Konieczna S; Rademakers R; Baker M; Berdynski M; Brockhuis B; Barcikowska M; Zekanowski C; Heilman KM; Wszolek ZK; Slawek J
    Neurocase; 2014; 20(1):69-86. PubMed ID: 23121543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical heterogeneity of frontotemporal dementia and Parkinsonism linked to chromosome 17 caused by MAPT N279K mutation in relation to tau positron emission tomography features.
    Ikeda A; Shimada H; Nishioka K; Takanashi M; Hayashida A; Li Y; Yoshino H; Funayama M; Ueno Y; Hatano T; Sahara N; Suhara T; Higuchi M; Hattori N
    Mov Disord; 2019 Apr; 34(4):568-574. PubMed ID: 30773680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and Pathological Features of FTDP-17 with MAPT p.K298_H299insQ Mutation.
    Morino H; Kurashige T; Matsuda Y; Ono M; Sahara N; Miyasaka T; Soeda Y; Shimada H; Yamazaki Y; Takahashi T; Izumi Y; Ito H; Maruyama H; Higuchi M; Arihiro K; Suhara T; Takashima A; Kawakami H
    Mov Disord Clin Pract; 2024 Jun; 11(6):720-727. PubMed ID: 38605589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical, pathological, and genetic characteristics of frontotemporal dementia and parkinsonism linked to chromosome 17 with mutations in the MAPT and PGRN].
    Tsuboi Y
    Brain Nerve; 2009 Nov; 61(11):1285-91. PubMed ID: 19938685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic heterogeneity in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) due to microtubule-associated protein tau (MAPT) p.P301L mutation, including a patient with globular glial tauopathy.
    Tacik P; Sanchez-Contreras M; DeTure M; Murray ME; Rademakers R; Ross OA; Wszolek ZK; Parisi JE; Knopman DS; Petersen RC; Dickson DW
    Neuropathol Appl Neurobiol; 2017 Apr; 43(3):200-214. PubMed ID: 27859539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frontotemporal dementia and parkinsonism linked to chromosome 17--the first Polish family.
    Narożańska E; Jasińska-Myga B; Sitek EJ; Robowski P; Brockhuis B; Lass P; Dubaniewicz M; Wieczorek D; Baker M; Rademakers R; Wszolek ZK; Sławek J
    Eur J Neurol; 2011 Mar; 18(3):535-7. PubMed ID: 20561037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and Genetic Study of the First Japanese FTDP-17 Patient with a Mutation of +3 in Intron 10 in the MAPT Gene.
    Nan H; Takaki R; Shimozono K; Ichinose Y; Koh K; Takiyama Y
    Intern Med; 2019 Aug; 58(16):2397-2400. PubMed ID: 30996196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal characterization of two siblings with frontotemporal dementia and parkinsonism linked to chromosome 17 associated with the S305N tau mutation.
    Boeve BF; Tremont-Lukats IW; Waclawik AJ; Murrell JR; Hermann B; Jack CR; Shiung MM; Smith GE; Nair AR; Lindor N; Koppikar V; Ghetti B
    Brain; 2005 Apr; 128(Pt 4):752-72. PubMed ID: 15615814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frontotemporal dementia with Parkinsonism linked to chromosome-17 mutations enhance tau oligomer formation.
    Maeda S; Sato Y; Takashima A
    Neurobiol Aging; 2018 Sep; 69():26-32. PubMed ID: 29852407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MAPT mutation associated with frontotemporal dementia and parkinsonism (FTDP-17).
    Haussmann R; Wysocki M; Brandt MD; Hermann A; Donix M
    Int Psychogeriatr; 2017 May; 29(5):869-871. PubMed ID: 27905268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clinical, molecular genetics and pathological study of a FTDP-17 family with a heterozygous splicing variant c.823-10G>T at the intron 9/exon 10 of the MAPT gene.
    Olszewska DA; Fearon C; McGuigan C; McVeigh TP; Houlden H; Polke JM; Lawlor B; Coen R; Hutchinson M; Hutton M; Beausang A; Delon I; Brett F; Sevastou I; Seto-Salvia N; de Silva R; Lynch T
    Neurobiol Aging; 2021 Oct; 106():343.e1-343.e8. PubMed ID: 34274155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 11C-CFT-PET in Presymptomatic FTDP-17: A Potential Biomarker Predicting Onset.
    Wu L; Liu J; Feng X; Dong J; Qin W; Liu Y; Wang J; Lu J; Chen K; Wang Y; Jia J
    J Alzheimers Dis; 2018; 61(2):613-618. PubMed ID: 29226866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrasting genotypes of the tau gene in two phenotypically distinct patients with P301L mutation of frontotemporal dementia and parkinsonism linked to chromosome 17.
    Kobayashi T; Mori H; Okuma Y; Dickson DW; Cookson N; Tsuboi Y; Motoi Y; Tanaka R; Miyashita N; Anno M; Narabayashi H; Mizuno Y
    J Neurol; 2002 Jun; 249(6):669-75. PubMed ID: 12111297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refining frontotemporal dementia with parkinsonism linked to chromosome 17: introducing FTDP-17 (MAPT) and FTDP-17 (PGRN).
    Boeve BF; Hutton M
    Arch Neurol; 2008 Apr; 65(4):460-4. PubMed ID: 18413467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and genetic features of families with frontotemporal dementia and parkinsonism linked to chromosome 17 with a P301S tau mutation.
    Baba Y; Baker MC; Le Ber I; Brice A; Maeck L; Kohlhase J; Yasuda M; Stoppe G; Bugiani O; Sperfeld AD; Tsuboi Y; Uitti RJ; Farrer MJ; Ghetti B; Hutton ML; Wszolek ZK
    J Neural Transm (Vienna); 2007 Jul; 114(7):947-50. PubMed ID: 17318302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrafamilial variable phenotype including corticobasal syndrome in a family with p.P301L mutation in the MAPT gene: first report in South America.
    Gatto EM; Allegri RF; Da Prat G; Chrem Mendez P; Hanna DS; Dorschner MO; Surace EI; Zabetian CP; Mata IF
    Neurobiol Aging; 2017 May; 53():195.e11-195.e17. PubMed ID: 28268100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial early onset frontotemporal dementia caused by a novel S356T MAPT mutation, initially diagnosed as schizophrenia.
    Momeni P; Wickremaratchi MM; Bell J; Arnold R; Beer R; Hardy J; Revesz T; Neal JW; Morris HR
    Clin Neurol Neurosurg; 2010 Dec; 112(10):917-20. PubMed ID: 20708332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of extent of tau pathology in patients with frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17), frontotemporal lobar degeneration with Pick bodies and early onset Alzheimer's disease.
    Shiarli AM; Jennings R; Shi J; Bailey K; Davidson Y; Tian J; Bigio EH; Ghetti B; Murrell JR; Delisle MB; Mirra S; Crain B; Zolo P; Arima K; Iseki E; Murayama S; Kretzschmar H; Neumann M; Lippa C; Halliday G; Mackenzie J; Khan N; Ravid R; Dickson D; Wszolek Z; Iwatsubo T; Pickering-Brown SM; Mann DM
    Neuropathol Appl Neurobiol; 2006 Aug; 32(4):374-87. PubMed ID: 16866983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).
    Wszolek ZK; Tsuboi Y; Ghetti B; Pickering-Brown S; Baba Y; Cheshire WP
    Orphanet J Rare Dis; 2006 Aug; 1():30. PubMed ID: 16899117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo and postmortem clinicoanatomical correlations in frontotemporal dementia and parkinsonism linked to chromosome 17.
    Ghetti B; Spina S; Murrell JR; Huey ED; Pietrini P; Sweeney B; Wassermann EM; Keohane C; Farlow MR; Grafman J
    Neurodegener Dis; 2008; 5(3-4):215-7. PubMed ID: 18322394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.